nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoconazole—CYP27B1—multiple sclerosis	0.285	0.54	CbGaD
Ketoconazole—CYP24A1—multiple sclerosis	0.242	0.46	CbGaD
Ketoconazole—CYP17A1—Dexamethasone—multiple sclerosis	0.0311	0.0955	CbGbCtD
Ketoconazole—CYP1B1—Mitoxantrone—multiple sclerosis	0.0288	0.0885	CbGbCtD
Ketoconazole—CYP11A1—Dexamethasone—multiple sclerosis	0.026	0.0799	CbGbCtD
Ketoconazole—CYP19A1—Betamethasone—multiple sclerosis	0.0208	0.0639	CbGbCtD
Ketoconazole—SLCO1A2—Prednisolone—multiple sclerosis	0.0161	0.0494	CbGbCtD
Ketoconazole—SLCO1A2—Prednisone—multiple sclerosis	0.0152	0.0466	CbGbCtD
Ketoconazole—CYP1B1—Dexamethasone—multiple sclerosis	0.0149	0.0459	CbGbCtD
Ketoconazole—ABCB11—Dexamethasone—multiple sclerosis	0.0149	0.0459	CbGbCtD
Ketoconazole—CYP2A6—Prednisolone—multiple sclerosis	0.013	0.04	CbGbCtD
Ketoconazole—CYP19A1—Dexamethasone—multiple sclerosis	0.0121	0.0372	CbGbCtD
Ketoconazole—CYP2D6—Fingolimod—multiple sclerosis	0.0099	0.0304	CbGbCtD
Ketoconazole—SLCO1A2—Dexamethasone—multiple sclerosis	0.00948	0.0291	CbGbCtD
Ketoconazole—CYP2A6—Dexamethasone—multiple sclerosis	0.00768	0.0236	CbGbCtD
Ketoconazole—SLCO1A2—Methotrexate—multiple sclerosis	0.00762	0.0234	CbGbCtD
Ketoconazole—ABCB1—Methylprednisolone—multiple sclerosis	0.00677	0.0208	CbGbCtD
Ketoconazole—CYP1A1—Dexamethasone—multiple sclerosis	0.00656	0.0201	CbGbCtD
Ketoconazole—CYP3A4—Fingolimod—multiple sclerosis	0.0063	0.0193	CbGbCtD
Ketoconazole—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.00525	0.0161	CbGbCtD
Ketoconazole—CYP3A7—Dexamethasone—multiple sclerosis	0.00525	0.0161	CbGbCtD
Ketoconazole—CYP2C19—Prednisone—multiple sclerosis	0.00509	0.0156	CbGbCtD
Ketoconazole—CYP2B6—Dexamethasone—multiple sclerosis	0.005	0.0153	CbGbCtD
Ketoconazole—ABCB1—Mitoxantrone—multiple sclerosis	0.00494	0.0152	CbGbCtD
Ketoconazole—ABCB1—Betamethasone—multiple sclerosis	0.0044	0.0135	CbGbCtD
Ketoconazole—ABCB1—Prednisolone—multiple sclerosis	0.00435	0.0133	CbGbCtD
Ketoconazole—ABCB1—Prednisone—multiple sclerosis	0.0041	0.0126	CbGbCtD
Ketoconazole—CYP3A4—Methylprednisolone—multiple sclerosis	0.00406	0.0125	CbGbCtD
Ketoconazole—CYP3A5—Dexamethasone—multiple sclerosis	0.00394	0.0121	CbGbCtD
Ketoconazole—CYP2C8—Dexamethasone—multiple sclerosis	0.00378	0.0116	CbGbCtD
Ketoconazole—CYP2C19—Dexamethasone—multiple sclerosis	0.00317	0.00975	CbGbCtD
Ketoconazole—CYP3A4—Triamcinolone—multiple sclerosis	0.00308	0.00944	CbGbCtD
Ketoconazole—CYP3A4—Mitoxantrone—multiple sclerosis	0.00296	0.00909	CbGbCtD
Ketoconazole—CYP2C9—Dexamethasone—multiple sclerosis	0.00264	0.0081	CbGbCtD
Ketoconazole—CYP3A4—Betamethasone—multiple sclerosis	0.00264	0.0081	CbGbCtD
Ketoconazole—CYP3A4—Prednisolone—multiple sclerosis	0.0026	0.00799	CbGbCtD
Ketoconazole—ABCB1—Dexamethasone—multiple sclerosis	0.00256	0.00787	CbGbCtD
Ketoconazole—CYP3A4—Prednisone—multiple sclerosis	0.00246	0.00755	CbGbCtD
Ketoconazole—CYP2D6—Dexamethasone—multiple sclerosis	0.00241	0.00741	CbGbCtD
Ketoconazole—ABCB1—Methotrexate—multiple sclerosis	0.00206	0.00632	CbGbCtD
Ketoconazole—CYP3A4—Dexamethasone—multiple sclerosis	0.00153	0.00471	CbGbCtD
Ketoconazole—Arrhythmia—Dexamethasone—multiple sclerosis	9.12e-05	0.00152	CcSEcCtD
Ketoconazole—Ill-defined disorder—Triamcinolone—multiple sclerosis	9.09e-05	0.00152	CcSEcCtD
Ketoconazole—Ill-defined disorder—Methylprednisolone—multiple sclerosis	9.07e-05	0.00151	CcSEcCtD
Ketoconazole—Constipation—Mitoxantrone—multiple sclerosis	9.06e-05	0.00151	CcSEcCtD
Ketoconazole—Pain—Mitoxantrone—multiple sclerosis	9.06e-05	0.00151	CcSEcCtD
Ketoconazole—Alopecia—Dexamethasone—multiple sclerosis	9.02e-05	0.00151	CcSEcCtD
Ketoconazole—Alopecia—Betamethasone—multiple sclerosis	9.02e-05	0.00151	CcSEcCtD
Ketoconazole—Diarrhoea—Azathioprine—multiple sclerosis	8.97e-05	0.0015	CcSEcCtD
Ketoconazole—Discomfort—Prednisolone—multiple sclerosis	8.96e-05	0.0015	CcSEcCtD
Ketoconazole—Angioedema—Triamcinolone—multiple sclerosis	8.95e-05	0.00149	CcSEcCtD
Ketoconazole—Angioedema—Methylprednisolone—multiple sclerosis	8.93e-05	0.00149	CcSEcCtD
Ketoconazole—Erythema—Dexamethasone—multiple sclerosis	8.89e-05	0.00148	CcSEcCtD
Ketoconazole—Erythema—Betamethasone—multiple sclerosis	8.89e-05	0.00148	CcSEcCtD
Ketoconazole—Malaise—Triamcinolone—multiple sclerosis	8.83e-05	0.00147	CcSEcCtD
Ketoconazole—Malaise—Methylprednisolone—multiple sclerosis	8.81e-05	0.00147	CcSEcCtD
Ketoconazole—Connective tissue disorder—Prednisone—multiple sclerosis	8.74e-05	0.00146	CcSEcCtD
Ketoconazole—Feeling abnormal—Mitoxantrone—multiple sclerosis	8.73e-05	0.00146	CcSEcCtD
Ketoconazole—Anaphylactic shock—Prednisolone—multiple sclerosis	8.69e-05	0.00145	CcSEcCtD
Ketoconazole—Dizziness—Azathioprine—multiple sclerosis	8.67e-05	0.00145	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	8.66e-05	0.00145	CcSEcCtD
Ketoconazole—Erectile dysfunction—Methotrexate—multiple sclerosis	8.55e-05	0.00143	CcSEcCtD
Ketoconazole—Photosensitivity reaction—Methotrexate—multiple sclerosis	8.47e-05	0.00141	CcSEcCtD
Ketoconazole—Urticaria—Mitoxantrone—multiple sclerosis	8.42e-05	0.00141	CcSEcCtD
Ketoconazole—Body temperature increased—Mitoxantrone—multiple sclerosis	8.38e-05	0.0014	CcSEcCtD
Ketoconazole—Abdominal pain—Mitoxantrone—multiple sclerosis	8.38e-05	0.0014	CcSEcCtD
Ketoconazole—Myalgia—Triamcinolone—multiple sclerosis	8.34e-05	0.00139	CcSEcCtD
Ketoconazole—Vomiting—Azathioprine—multiple sclerosis	8.33e-05	0.00139	CcSEcCtD
Ketoconazole—Arthralgia—Methylprednisolone—multiple sclerosis	8.32e-05	0.00139	CcSEcCtD
Ketoconazole—Myalgia—Methylprednisolone—multiple sclerosis	8.32e-05	0.00139	CcSEcCtD
Ketoconazole—Eye disorder—Prednisone—multiple sclerosis	8.31e-05	0.00139	CcSEcCtD
Ketoconazole—Rash—Azathioprine—multiple sclerosis	8.26e-05	0.00138	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	8.26e-05	0.00138	CcSEcCtD
Ketoconazole—Dermatitis—Azathioprine—multiple sclerosis	8.26e-05	0.00138	CcSEcCtD
Ketoconazole—Ill-defined disorder—Dexamethasone—multiple sclerosis	8.25e-05	0.00138	CcSEcCtD
Ketoconazole—Ill-defined disorder—Betamethasone—multiple sclerosis	8.25e-05	0.00138	CcSEcCtD
Ketoconazole—Discomfort—Triamcinolone—multiple sclerosis	8.24e-05	0.00138	CcSEcCtD
Ketoconazole—Discomfort—Methylprednisolone—multiple sclerosis	8.22e-05	0.00137	CcSEcCtD
Ketoconazole—Headache—Azathioprine—multiple sclerosis	8.21e-05	0.00137	CcSEcCtD
Ketoconazole—Dry mouth—Triamcinolone—multiple sclerosis	8.16e-05	0.00136	CcSEcCtD
Ketoconazole—Angioedema—Dexamethasone—multiple sclerosis	8.12e-05	0.00136	CcSEcCtD
Ketoconazole—Angioedema—Betamethasone—multiple sclerosis	8.12e-05	0.00136	CcSEcCtD
Ketoconazole—Angiopathy—Prednisone—multiple sclerosis	8.07e-05	0.00135	CcSEcCtD
Ketoconazole—Immune system disorder—Prednisone—multiple sclerosis	8.03e-05	0.00134	CcSEcCtD
Ketoconazole—Malaise—Betamethasone—multiple sclerosis	8.01e-05	0.00134	CcSEcCtD
Ketoconazole—Malaise—Dexamethasone—multiple sclerosis	8.01e-05	0.00134	CcSEcCtD
Ketoconazole—Anaphylactic shock—Triamcinolone—multiple sclerosis	7.99e-05	0.00133	CcSEcCtD
Ketoconazole—Anaphylactic shock—Methylprednisolone—multiple sclerosis	7.98e-05	0.00133	CcSEcCtD
Ketoconazole—Arrhythmia—Prednisone—multiple sclerosis	7.94e-05	0.00133	CcSEcCtD
Ketoconazole—Insomnia—Prednisolone—multiple sclerosis	7.86e-05	0.00131	CcSEcCtD
Ketoconazole—Alopecia—Prednisone—multiple sclerosis	7.86e-05	0.00131	CcSEcCtD
Ketoconazole—Hepatobiliary disease—Methotrexate—multiple sclerosis	7.83e-05	0.00131	CcSEcCtD
Ketoconazole—Nervous system disorder—Methylprednisolone—multiple sclerosis	7.82e-05	0.00131	CcSEcCtD
Ketoconazole—Epistaxis—Methotrexate—multiple sclerosis	7.81e-05	0.0013	CcSEcCtD
Ketoconazole—Hypersensitivity—Mitoxantrone—multiple sclerosis	7.81e-05	0.0013	CcSEcCtD
Ketoconazole—Paraesthesia—Prednisolone—multiple sclerosis	7.81e-05	0.0013	CcSEcCtD
Ketoconazole—Mental disorder—Prednisone—multiple sclerosis	7.79e-05	0.0013	CcSEcCtD
Ketoconazole—Nausea—Azathioprine—multiple sclerosis	7.79e-05	0.0013	CcSEcCtD
Ketoconazole—Skin disorder—Methylprednisolone—multiple sclerosis	7.75e-05	0.00129	CcSEcCtD
Ketoconazole—Malnutrition—Prednisone—multiple sclerosis	7.74e-05	0.00129	CcSEcCtD
Ketoconazole—Erythema—Prednisone—multiple sclerosis	7.74e-05	0.00129	CcSEcCtD
Ketoconazole—Asthenia—Mitoxantrone—multiple sclerosis	7.6e-05	0.00127	CcSEcCtD
Ketoconazole—Myalgia—Dexamethasone—multiple sclerosis	7.57e-05	0.00126	CcSEcCtD
Ketoconazole—Myalgia—Betamethasone—multiple sclerosis	7.57e-05	0.00126	CcSEcCtD
Ketoconazole—Discomfort—Betamethasone—multiple sclerosis	7.48e-05	0.00125	CcSEcCtD
Ketoconazole—Discomfort—Dexamethasone—multiple sclerosis	7.48e-05	0.00125	CcSEcCtD
Ketoconazole—Pain—Prednisolone—multiple sclerosis	7.43e-05	0.00124	CcSEcCtD
Ketoconazole—Hepatitis—Methotrexate—multiple sclerosis	7.43e-05	0.00124	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	7.28e-05	0.00122	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	7.27e-05	0.00121	CcSEcCtD
Ketoconazole—Anaphylactic shock—Betamethasone—multiple sclerosis	7.25e-05	0.00121	CcSEcCtD
Ketoconazole—Anaphylactic shock—Dexamethasone—multiple sclerosis	7.25e-05	0.00121	CcSEcCtD
Ketoconazole—Diarrhoea—Mitoxantrone—multiple sclerosis	7.25e-05	0.00121	CcSEcCtD
Ketoconazole—Insomnia—Triamcinolone—multiple sclerosis	7.23e-05	0.00121	CcSEcCtD
Ketoconazole—Insomnia—Methylprednisolone—multiple sclerosis	7.21e-05	0.0012	CcSEcCtD
Ketoconazole—Ill-defined disorder—Prednisone—multiple sclerosis	7.18e-05	0.0012	CcSEcCtD
Ketoconazole—Paraesthesia—Triamcinolone—multiple sclerosis	7.18e-05	0.0012	CcSEcCtD
Ketoconazole—Feeling abnormal—Prednisolone—multiple sclerosis	7.16e-05	0.0012	CcSEcCtD
Ketoconazole—Paraesthesia—Methylprednisolone—multiple sclerosis	7.16e-05	0.0012	CcSEcCtD
Ketoconazole—Nervous system disorder—Dexamethasone—multiple sclerosis	7.11e-05	0.00119	CcSEcCtD
Ketoconazole—Nervous system disorder—Betamethasone—multiple sclerosis	7.11e-05	0.00119	CcSEcCtD
Ketoconazole—Thrombocytopenia—Betamethasone—multiple sclerosis	7.1e-05	0.00119	CcSEcCtD
Ketoconazole—Thrombocytopenia—Dexamethasone—multiple sclerosis	7.1e-05	0.00119	CcSEcCtD
Ketoconazole—Angioedema—Prednisone—multiple sclerosis	7.07e-05	0.00118	CcSEcCtD
Ketoconazole—Dyspepsia—Triamcinolone—multiple sclerosis	7.04e-05	0.00117	CcSEcCtD
Ketoconazole—Erythema multiforme—Methotrexate—multiple sclerosis	7.03e-05	0.00117	CcSEcCtD
Ketoconazole—Dyspepsia—Methylprednisolone—multiple sclerosis	7.02e-05	0.00117	CcSEcCtD
Ketoconazole—Malaise—Prednisone—multiple sclerosis	6.98e-05	0.00117	CcSEcCtD
Ketoconazole—Eye disorder—Methotrexate—multiple sclerosis	6.94e-05	0.00116	CcSEcCtD
Ketoconazole—Anorexia—Betamethasone—multiple sclerosis	6.91e-05	0.00115	CcSEcCtD
Ketoconazole—Anorexia—Dexamethasone—multiple sclerosis	6.91e-05	0.00115	CcSEcCtD
Ketoconazole—Urticaria—Prednisolone—multiple sclerosis	6.91e-05	0.00115	CcSEcCtD
Ketoconazole—Fatigue—Triamcinolone—multiple sclerosis	6.89e-05	0.00115	CcSEcCtD
Ketoconazole—Fatigue—Methylprednisolone—multiple sclerosis	6.88e-05	0.00115	CcSEcCtD
Ketoconazole—Pain—Triamcinolone—multiple sclerosis	6.84e-05	0.00114	CcSEcCtD
Ketoconazole—Angiopathy—Methotrexate—multiple sclerosis	6.74e-05	0.00113	CcSEcCtD
Ketoconazole—Vomiting—Mitoxantrone—multiple sclerosis	6.74e-05	0.00112	CcSEcCtD
Ketoconazole—Immune system disorder—Methotrexate—multiple sclerosis	6.71e-05	0.00112	CcSEcCtD
Ketoconazole—Mediastinal disorder—Methotrexate—multiple sclerosis	6.7e-05	0.00112	CcSEcCtD
Ketoconazole—Rash—Mitoxantrone—multiple sclerosis	6.68e-05	0.00112	CcSEcCtD
Ketoconazole—Dermatitis—Mitoxantrone—multiple sclerosis	6.67e-05	0.00111	CcSEcCtD
Ketoconazole—Chills—Methotrexate—multiple sclerosis	6.67e-05	0.00111	CcSEcCtD
Ketoconazole—Headache—Mitoxantrone—multiple sclerosis	6.64e-05	0.00111	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	6.61e-05	0.0011	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	6.61e-05	0.0011	CcSEcCtD
Ketoconazole—Myalgia—Prednisone—multiple sclerosis	6.59e-05	0.0011	CcSEcCtD
Ketoconazole—Arthralgia—Prednisone—multiple sclerosis	6.59e-05	0.0011	CcSEcCtD
Ketoconazole—Feeling abnormal—Triamcinolone—multiple sclerosis	6.59e-05	0.0011	CcSEcCtD
Ketoconazole—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.57e-05	0.0011	CcSEcCtD
Ketoconazole—Alopecia—Methotrexate—multiple sclerosis	6.57e-05	0.0011	CcSEcCtD
Ketoconazole—Insomnia—Dexamethasone—multiple sclerosis	6.56e-05	0.0011	CcSEcCtD
Ketoconazole—Insomnia—Betamethasone—multiple sclerosis	6.56e-05	0.0011	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	6.54e-05	0.00109	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.52e-05	0.00109	CcSEcCtD
Ketoconazole—Paraesthesia—Dexamethasone—multiple sclerosis	6.51e-05	0.00109	CcSEcCtD
Ketoconazole—Paraesthesia—Betamethasone—multiple sclerosis	6.51e-05	0.00109	CcSEcCtD
Ketoconazole—Discomfort—Prednisone—multiple sclerosis	6.51e-05	0.00109	CcSEcCtD
Ketoconazole—Mental disorder—Methotrexate—multiple sclerosis	6.51e-05	0.00109	CcSEcCtD
Ketoconazole—Erythema—Methotrexate—multiple sclerosis	6.47e-05	0.00108	CcSEcCtD
Ketoconazole—Malnutrition—Methotrexate—multiple sclerosis	6.47e-05	0.00108	CcSEcCtD
Ketoconazole—Hypersensitivity—Prednisolone—multiple sclerosis	6.4e-05	0.00107	CcSEcCtD
Ketoconazole—Dyspepsia—Betamethasone—multiple sclerosis	6.38e-05	0.00107	CcSEcCtD
Ketoconazole—Dyspepsia—Dexamethasone—multiple sclerosis	6.38e-05	0.00107	CcSEcCtD
Ketoconazole—Urticaria—Triamcinolone—multiple sclerosis	6.35e-05	0.00106	CcSEcCtD
Ketoconazole—Urticaria—Methylprednisolone—multiple sclerosis	6.34e-05	0.00106	CcSEcCtD
Ketoconazole—Dysgeusia—Methotrexate—multiple sclerosis	6.33e-05	0.00106	CcSEcCtD
Ketoconazole—Body temperature increased—Triamcinolone—multiple sclerosis	6.32e-05	0.00105	CcSEcCtD
Ketoconazole—Anaphylactic shock—Prednisone—multiple sclerosis	6.32e-05	0.00105	CcSEcCtD
Ketoconazole—Abdominal pain—Methylprednisolone—multiple sclerosis	6.31e-05	0.00105	CcSEcCtD
Ketoconazole—Decreased appetite—Dexamethasone—multiple sclerosis	6.31e-05	0.00105	CcSEcCtD
Ketoconazole—Decreased appetite—Betamethasone—multiple sclerosis	6.31e-05	0.00105	CcSEcCtD
Ketoconazole—Nausea—Mitoxantrone—multiple sclerosis	6.29e-05	0.00105	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.26e-05	0.00105	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.26e-05	0.00105	CcSEcCtD
Ketoconazole—Fatigue—Dexamethasone—multiple sclerosis	6.25e-05	0.00104	CcSEcCtD
Ketoconazole—Fatigue—Betamethasone—multiple sclerosis	6.25e-05	0.00104	CcSEcCtD
Ketoconazole—Pain—Betamethasone—multiple sclerosis	6.2e-05	0.00104	CcSEcCtD
Ketoconazole—Pain—Dexamethasone—multiple sclerosis	6.2e-05	0.00104	CcSEcCtD
Ketoconazole—Nervous system disorder—Prednisone—multiple sclerosis	6.19e-05	0.00103	CcSEcCtD
Ketoconazole—Skin disorder—Prednisone—multiple sclerosis	6.14e-05	0.00102	CcSEcCtD
Ketoconazole—Anorexia—Prednisone—multiple sclerosis	6.02e-05	0.00101	CcSEcCtD
Ketoconazole—Ill-defined disorder—Methotrexate—multiple sclerosis	6e-05	0.001	CcSEcCtD
Ketoconazole—Feeling abnormal—Dexamethasone—multiple sclerosis	5.98e-05	0.000998	CcSEcCtD
Ketoconazole—Feeling abnormal—Betamethasone—multiple sclerosis	5.98e-05	0.000998	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	5.93e-05	0.00099	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Betamethasone—multiple sclerosis	5.93e-05	0.00099	CcSEcCtD
Ketoconazole—Hypersensitivity—Triamcinolone—multiple sclerosis	5.89e-05	0.000983	CcSEcCtD
Ketoconazole—Hypersensitivity—Methylprednisolone—multiple sclerosis	5.88e-05	0.000981	CcSEcCtD
Ketoconazole—Malaise—Methotrexate—multiple sclerosis	5.83e-05	0.000974	CcSEcCtD
Ketoconazole—Leukopenia—Methotrexate—multiple sclerosis	5.79e-05	0.000967	CcSEcCtD
Ketoconazole—Urticaria—Betamethasone—multiple sclerosis	5.76e-05	0.000962	CcSEcCtD
Ketoconazole—Urticaria—Dexamethasone—multiple sclerosis	5.76e-05	0.000962	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	5.75e-05	0.000961	CcSEcCtD
Ketoconazole—Dizziness—Prednisolone—multiple sclerosis	5.75e-05	0.00096	CcSEcCtD
Ketoconazole—Asthenia—Triamcinolone—multiple sclerosis	5.74e-05	0.000957	CcSEcCtD
Ketoconazole—Abdominal pain—Betamethasone—multiple sclerosis	5.73e-05	0.000957	CcSEcCtD
Ketoconazole—Body temperature increased—Dexamethasone—multiple sclerosis	5.73e-05	0.000957	CcSEcCtD
Ketoconazole—Abdominal pain—Dexamethasone—multiple sclerosis	5.73e-05	0.000957	CcSEcCtD
Ketoconazole—Body temperature increased—Betamethasone—multiple sclerosis	5.73e-05	0.000957	CcSEcCtD
Ketoconazole—Asthenia—Methylprednisolone—multiple sclerosis	5.72e-05	0.000955	CcSEcCtD
Ketoconazole—Insomnia—Prednisone—multiple sclerosis	5.71e-05	0.000954	CcSEcCtD
Ketoconazole—Paraesthesia—Prednisone—multiple sclerosis	5.67e-05	0.000947	CcSEcCtD
Ketoconazole—Pruritus—Triamcinolone—multiple sclerosis	5.66e-05	0.000944	CcSEcCtD
Ketoconazole—Pruritus—Methylprednisolone—multiple sclerosis	5.64e-05	0.000942	CcSEcCtD
Ketoconazole—Dyspepsia—Prednisone—multiple sclerosis	5.56e-05	0.000928	CcSEcCtD
Ketoconazole—Myalgia—Methotrexate—multiple sclerosis	5.51e-05	0.000919	CcSEcCtD
Ketoconazole—Arthralgia—Methotrexate—multiple sclerosis	5.51e-05	0.000919	CcSEcCtD
Ketoconazole—Decreased appetite—Prednisone—multiple sclerosis	5.49e-05	0.000917	CcSEcCtD
Ketoconazole—Rash—Prednisolone—multiple sclerosis	5.48e-05	0.000915	CcSEcCtD
Ketoconazole—Dermatitis—Prednisolone—multiple sclerosis	5.48e-05	0.000914	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.47e-05	0.000913	CcSEcCtD
Ketoconazole—Diarrhoea—Methylprednisolone—multiple sclerosis	5.46e-05	0.000911	CcSEcCtD
Ketoconazole—Fatigue—Prednisone—multiple sclerosis	5.45e-05	0.000909	CcSEcCtD
Ketoconazole—Headache—Prednisolone—multiple sclerosis	5.45e-05	0.000909	CcSEcCtD
Ketoconazole—Discomfort—Methotrexate—multiple sclerosis	5.44e-05	0.000908	CcSEcCtD
Ketoconazole—Constipation—Prednisone—multiple sclerosis	5.4e-05	0.000902	CcSEcCtD
Ketoconazole—Dizziness—Triamcinolone—multiple sclerosis	5.29e-05	0.000882	CcSEcCtD
Ketoconazole—Anaphylactic shock—Methotrexate—multiple sclerosis	5.28e-05	0.000881	CcSEcCtD
Ketoconazole—Dizziness—Methylprednisolone—multiple sclerosis	5.27e-05	0.00088	CcSEcCtD
Ketoconazole—Feeling abnormal—Prednisone—multiple sclerosis	5.21e-05	0.000869	CcSEcCtD
Ketoconazole—Asthenia—Betamethasone—multiple sclerosis	5.2e-05	0.000869	CcSEcCtD
Ketoconazole—Asthenia—Dexamethasone—multiple sclerosis	5.2e-05	0.000869	CcSEcCtD
Ketoconazole—Nervous system disorder—Methotrexate—multiple sclerosis	5.18e-05	0.000864	CcSEcCtD
Ketoconazole—Thrombocytopenia—Methotrexate—multiple sclerosis	5.17e-05	0.000863	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Prednisone—multiple sclerosis	5.17e-05	0.000862	CcSEcCtD
Ketoconazole—Nausea—Prednisolone—multiple sclerosis	5.16e-05	0.000862	CcSEcCtD
Ketoconazole—Pruritus—Dexamethasone—multiple sclerosis	5.13e-05	0.000857	CcSEcCtD
Ketoconazole—Pruritus—Betamethasone—multiple sclerosis	5.13e-05	0.000857	CcSEcCtD
Ketoconazole—Skin disorder—Methotrexate—multiple sclerosis	5.13e-05	0.000856	CcSEcCtD
Ketoconazole—Vomiting—Triamcinolone—multiple sclerosis	5.08e-05	0.000848	CcSEcCtD
Ketoconazole—Vomiting—Methylprednisolone—multiple sclerosis	5.07e-05	0.000847	CcSEcCtD
Ketoconazole—Rash—Triamcinolone—multiple sclerosis	5.04e-05	0.000841	CcSEcCtD
Ketoconazole—Dermatitis—Triamcinolone—multiple sclerosis	5.04e-05	0.000841	CcSEcCtD
Ketoconazole—Anorexia—Methotrexate—multiple sclerosis	5.03e-05	0.00084	CcSEcCtD
Ketoconazole—Rash—Methylprednisolone—multiple sclerosis	5.03e-05	0.00084	CcSEcCtD
Ketoconazole—Dermatitis—Methylprednisolone—multiple sclerosis	5.02e-05	0.000839	CcSEcCtD
Ketoconazole—Urticaria—Prednisone—multiple sclerosis	5.02e-05	0.000838	CcSEcCtD
Ketoconazole—Headache—Triamcinolone—multiple sclerosis	5.01e-05	0.000836	CcSEcCtD
Ketoconazole—Headache—Methylprednisolone—multiple sclerosis	5e-05	0.000834	CcSEcCtD
Ketoconazole—Abdominal pain—Prednisone—multiple sclerosis	4.99e-05	0.000834	CcSEcCtD
Ketoconazole—Body temperature increased—Prednisone—multiple sclerosis	4.99e-05	0.000834	CcSEcCtD
Ketoconazole—Diarrhoea—Dexamethasone—multiple sclerosis	4.96e-05	0.000828	CcSEcCtD
Ketoconazole—Diarrhoea—Betamethasone—multiple sclerosis	4.96e-05	0.000828	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	4.81e-05	0.000803	CcSEcCtD
Ketoconazole—Dizziness—Betamethasone—multiple sclerosis	4.8e-05	0.000801	CcSEcCtD
Ketoconazole—Dizziness—Dexamethasone—multiple sclerosis	4.8e-05	0.000801	CcSEcCtD
Ketoconazole—Insomnia—Methotrexate—multiple sclerosis	4.77e-05	0.000797	CcSEcCtD
Ketoconazole—Nausea—Triamcinolone—multiple sclerosis	4.75e-05	0.000793	CcSEcCtD
Ketoconazole—Paraesthesia—Methotrexate—multiple sclerosis	4.74e-05	0.000791	CcSEcCtD
Ketoconazole—Nausea—Methylprednisolone—multiple sclerosis	4.74e-05	0.000791	CcSEcCtD
Ketoconazole—Somnolence—Methotrexate—multiple sclerosis	4.69e-05	0.000783	CcSEcCtD
Ketoconazole—Hypersensitivity—Prednisone—multiple sclerosis	4.65e-05	0.000777	CcSEcCtD
Ketoconazole—Dyspepsia—Methotrexate—multiple sclerosis	4.65e-05	0.000776	CcSEcCtD
Ketoconazole—Vomiting—Dexamethasone—multiple sclerosis	4.61e-05	0.00077	CcSEcCtD
Ketoconazole—Vomiting—Betamethasone—multiple sclerosis	4.61e-05	0.00077	CcSEcCtD
Ketoconazole—Decreased appetite—Methotrexate—multiple sclerosis	4.59e-05	0.000766	CcSEcCtD
Ketoconazole—Rash—Betamethasone—multiple sclerosis	4.57e-05	0.000763	CcSEcCtD
Ketoconazole—Rash—Dexamethasone—multiple sclerosis	4.57e-05	0.000763	CcSEcCtD
Ketoconazole—Dermatitis—Betamethasone—multiple sclerosis	4.57e-05	0.000763	CcSEcCtD
Ketoconazole—Dermatitis—Dexamethasone—multiple sclerosis	4.57e-05	0.000763	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.56e-05	0.000761	CcSEcCtD
Ketoconazole—Fatigue—Methotrexate—multiple sclerosis	4.55e-05	0.00076	CcSEcCtD
Ketoconazole—Headache—Dexamethasone—multiple sclerosis	4.54e-05	0.000759	CcSEcCtD
Ketoconazole—Headache—Betamethasone—multiple sclerosis	4.54e-05	0.000759	CcSEcCtD
Ketoconazole—Asthenia—Prednisone—multiple sclerosis	4.53e-05	0.000757	CcSEcCtD
Ketoconazole—Pain—Methotrexate—multiple sclerosis	4.51e-05	0.000754	CcSEcCtD
Ketoconazole—Pruritus—Prednisone—multiple sclerosis	4.47e-05	0.000746	CcSEcCtD
Ketoconazole—Feeling abnormal—Methotrexate—multiple sclerosis	4.35e-05	0.000726	CcSEcCtD
Ketoconazole—Diarrhoea—Prednisone—multiple sclerosis	4.32e-05	0.000721	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.32e-05	0.000721	CcSEcCtD
Ketoconazole—Nausea—Dexamethasone—multiple sclerosis	4.31e-05	0.000719	CcSEcCtD
Ketoconazole—Nausea—Betamethasone—multiple sclerosis	4.31e-05	0.000719	CcSEcCtD
Ketoconazole—Urticaria—Methotrexate—multiple sclerosis	4.19e-05	0.0007	CcSEcCtD
Ketoconazole—Dizziness—Prednisone—multiple sclerosis	4.18e-05	0.000697	CcSEcCtD
Ketoconazole—Abdominal pain—Methotrexate—multiple sclerosis	4.17e-05	0.000697	CcSEcCtD
Ketoconazole—Body temperature increased—Methotrexate—multiple sclerosis	4.17e-05	0.000697	CcSEcCtD
Ketoconazole—Vomiting—Prednisone—multiple sclerosis	4.02e-05	0.00067	CcSEcCtD
Ketoconazole—Rash—Prednisone—multiple sclerosis	3.98e-05	0.000665	CcSEcCtD
Ketoconazole—Dermatitis—Prednisone—multiple sclerosis	3.98e-05	0.000664	CcSEcCtD
Ketoconazole—Headache—Prednisone—multiple sclerosis	3.96e-05	0.000661	CcSEcCtD
Ketoconazole—Hypersensitivity—Methotrexate—multiple sclerosis	3.89e-05	0.000649	CcSEcCtD
Ketoconazole—Asthenia—Methotrexate—multiple sclerosis	3.79e-05	0.000632	CcSEcCtD
Ketoconazole—Nausea—Prednisone—multiple sclerosis	3.75e-05	0.000626	CcSEcCtD
Ketoconazole—Pruritus—Methotrexate—multiple sclerosis	3.73e-05	0.000623	CcSEcCtD
Ketoconazole—Diarrhoea—Methotrexate—multiple sclerosis	3.61e-05	0.000603	CcSEcCtD
Ketoconazole—Dizziness—Methotrexate—multiple sclerosis	3.49e-05	0.000583	CcSEcCtD
Ketoconazole—Vomiting—Methotrexate—multiple sclerosis	3.36e-05	0.00056	CcSEcCtD
Ketoconazole—Rash—Methotrexate—multiple sclerosis	3.33e-05	0.000556	CcSEcCtD
Ketoconazole—Dermatitis—Methotrexate—multiple sclerosis	3.33e-05	0.000555	CcSEcCtD
Ketoconazole—Headache—Methotrexate—multiple sclerosis	3.31e-05	0.000552	CcSEcCtD
Ketoconazole—Nausea—Methotrexate—multiple sclerosis	3.14e-05	0.000523	CcSEcCtD
Ketoconazole—CYP1B1—Metabolism—CYP27B1—multiple sclerosis	1.2e-05	0.000138	CbGpPWpGaD
Ketoconazole—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	1.2e-05	0.000138	CbGpPWpGaD
Ketoconazole—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.19e-05	0.000137	CbGpPWpGaD
Ketoconazole—CYP21A2—Metabolism—ALB—multiple sclerosis	1.18e-05	0.000136	CbGpPWpGaD
Ketoconazole—CYP11B2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.18e-05	0.000135	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.18e-05	0.000135	CbGpPWpGaD
Ketoconazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.17e-05	0.000134	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—GPC5—multiple sclerosis	1.14e-05	0.000131	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—SRM—multiple sclerosis	1.14e-05	0.000131	CbGpPWpGaD
Ketoconazole—CYP51A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.12e-05	0.000128	CbGpPWpGaD
Ketoconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.11e-05	0.000128	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.11e-05	0.000128	CbGpPWpGaD
Ketoconazole—CYP11B2—Metabolism—BCHE—multiple sclerosis	1.11e-05	0.000128	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—SRM—multiple sclerosis	1.11e-05	0.000128	CbGpPWpGaD
Ketoconazole—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.11e-05	0.000128	CbGpPWpGaD
Ketoconazole—AR—Gene Expression—RPL5—multiple sclerosis	1.11e-05	0.000128	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.11e-05	0.000127	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—GPC5—multiple sclerosis	1.1e-05	0.000126	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	1.08e-05	0.000125	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	1.08e-05	0.000125	CbGpPWpGaD
Ketoconazole—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.08e-05	0.000124	CbGpPWpGaD
Ketoconazole—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.07e-05	0.000123	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.06e-05	0.000122	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.06e-05	0.000122	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.06e-05	0.000122	CbGpPWpGaD
Ketoconazole—CYP51A1—Metabolism—BCHE—multiple sclerosis	1.05e-05	0.000121	CbGpPWpGaD
Ketoconazole—CYP2B6—Biological oxidations—POMC—multiple sclerosis	1.05e-05	0.000121	CbGpPWpGaD
Ketoconazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	1.05e-05	0.000121	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—SRM—multiple sclerosis	1.05e-05	0.000121	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—RRM1—multiple sclerosis	1.05e-05	0.00012	CbGpPWpGaD
Ketoconazole—CYP26A1—Metabolism—APOE—multiple sclerosis	1.04e-05	0.00012	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.04e-05	0.00012	CbGpPWpGaD
Ketoconazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	1.03e-05	0.000118	CbGpPWpGaD
Ketoconazole—CYP3A5—Biological oxidations—POMC—multiple sclerosis	1.03e-05	0.000118	CbGpPWpGaD
Ketoconazole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	1.03e-05	0.000118	CbGpPWpGaD
Ketoconazole—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.03e-05	0.000118	CbGpPWpGaD
Ketoconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	1.03e-05	0.000118	CbGpPWpGaD
Ketoconazole—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.01e-05	0.000117	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.01e-05	0.000117	CbGpPWpGaD
Ketoconazole—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.01e-05	0.000116	CbGpPWpGaD
Ketoconazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	1.01e-05	0.000116	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	9.94e-06	0.000114	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	9.94e-06	0.000114	CbGpPWpGaD
Ketoconazole—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.93e-06	0.000114	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—GPC5—multiple sclerosis	9.92e-06	0.000114	CbGpPWpGaD
Ketoconazole—CYP1A1—Biological oxidations—POMC—multiple sclerosis	9.74e-06	0.000112	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.73e-06	0.000112	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—SRM—multiple sclerosis	9.63e-06	0.000111	CbGpPWpGaD
Ketoconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	9.6e-06	0.00011	CbGpPWpGaD
Ketoconazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	9.6e-06	0.00011	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism—BCHE—multiple sclerosis	9.59e-06	0.00011	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.52e-06	0.000109	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.49e-06	0.000109	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—RRM1—multiple sclerosis	9.46e-06	0.000109	CbGpPWpGaD
Ketoconazole—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.45e-06	0.000109	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—RRM1—multiple sclerosis	9.11e-06	0.000105	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—GPC5—multiple sclerosis	9.09e-06	0.000104	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	9.07e-06	0.000104	CbGpPWpGaD
Ketoconazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.02e-06	0.000104	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism—BCHE—multiple sclerosis	8.97e-06	0.000103	CbGpPWpGaD
Ketoconazole—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	8.97e-06	0.000103	CbGpPWpGaD
Ketoconazole—CYP26A1—Metabolism—POMC—multiple sclerosis	8.96e-06	0.000103	CbGpPWpGaD
Ketoconazole—CYP2C8—Biological oxidations—POMC—multiple sclerosis	8.93e-06	0.000103	CbGpPWpGaD
Ketoconazole—AR—Gene Expression—PGR—multiple sclerosis	8.74e-06	0.0001	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.68e-06	9.97e-05	CbGpPWpGaD
Ketoconazole—CYP27B1—Metabolism—APOE—multiple sclerosis	8.65e-06	9.94e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—SRM—multiple sclerosis	8.6e-06	9.88e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	8.59e-06	9.88e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—SRM—multiple sclerosis	8.39e-06	9.65e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	8.36e-06	9.61e-05	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.36e-06	9.61e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—RRM1—multiple sclerosis	8.22e-06	9.44e-05	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism—BCHE—multiple sclerosis	8.2e-06	9.43e-05	CbGpPWpGaD
Ketoconazole—CYP26A1—Metabolism—ALB—multiple sclerosis	8.17e-06	9.39e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.14e-06	9.35e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.12e-06	9.33e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	8.02e-06	9.21e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	8.02e-06	9.21e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Biological oxidations—POMC—multiple sclerosis	7.97e-06	9.16e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—SRM—multiple sclerosis	7.91e-06	9.09e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—SRM—multiple sclerosis	7.84e-06	9.01e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	7.84e-06	9.01e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	7.84e-06	9.01e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Allograft Rejection—TNF—multiple sclerosis	7.81e-06	8.97e-05	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.62e-06	8.76e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—RRM1—multiple sclerosis	7.53e-06	8.66e-05	CbGpPWpGaD
Ketoconazole—CYP27B1—Metabolism—POMC—multiple sclerosis	7.43e-06	8.54e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	7.4e-06	8.51e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	7.4e-06	8.51e-05	CbGpPWpGaD
Ketoconazole—CYP24A1—Metabolism—APOE—multiple sclerosis	7.35e-06	8.45e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.34e-06	8.44e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—GPC5—multiple sclerosis	7.33e-06	8.43e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Biological oxidations—POMC—multiple sclerosis	7.33e-06	8.42e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Biological oxidations—POMC—multiple sclerosis	7.27e-06	8.35e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.24e-06	8.32e-05	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—BCHE—multiple sclerosis	7.2e-06	8.28e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.19e-06	8.27e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—GPC5—multiple sclerosis	7.17e-06	8.24e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.07e-06	8.12e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.98e-06	8.02e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	6.79e-06	7.8e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	6.79e-06	7.8e-05	CbGpPWpGaD
Ketoconazole—CYP27B1—Metabolism—ALB—multiple sclerosis	6.77e-06	7.78e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—GPC5—multiple sclerosis	6.77e-06	7.78e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—SRM—multiple sclerosis	6.7e-06	7.7e-05	CbGpPWpGaD
Ketoconazole—CYP11B2—Metabolism—APOE—multiple sclerosis	6.69e-06	7.69e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.63e-06	7.62e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.36e-06	7.31e-05	CbGpPWpGaD
Ketoconazole—CYP51A1—Metabolism—APOE—multiple sclerosis	6.35e-06	7.29e-05	CbGpPWpGaD
Ketoconazole—CYP24A1—Metabolism—POMC—multiple sclerosis	6.32e-06	7.26e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.31e-06	7.25e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Biological oxidations—POMC—multiple sclerosis	6.21e-06	7.14e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—GPC5—multiple sclerosis	6.21e-06	7.14e-05	CbGpPWpGaD
Ketoconazole—AR—Gene Expression—VDR—multiple sclerosis	6.1e-06	7.02e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—RRM1—multiple sclerosis	6.08e-06	6.98e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.07e-06	6.98e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	6.06e-06	6.96e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	6.06e-06	6.96e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.05e-06	6.95e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—BCHE—multiple sclerosis	6.01e-06	6.91e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—RRM1—multiple sclerosis	5.94e-06	6.83e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.92e-06	6.81e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—CYP27B1—multiple sclerosis	5.91e-06	6.8e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—CYP24A1—multiple sclerosis	5.91e-06	6.8e-05	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism—APOE—multiple sclerosis	5.77e-06	6.63e-05	CbGpPWpGaD
Ketoconazole—CYP24A1—Metabolism—ALB—multiple sclerosis	5.76e-06	6.62e-05	CbGpPWpGaD
Ketoconazole—CYP11B2—Metabolism—POMC—multiple sclerosis	5.75e-06	6.61e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.75e-06	6.61e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—RRM1—multiple sclerosis	5.61e-06	6.45e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	5.57e-06	6.4e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	5.57e-06	6.4e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—GPC5—multiple sclerosis	5.54e-06	6.37e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.54e-06	6.36e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	5.52e-06	6.35e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	5.52e-06	6.35e-05	CbGpPWpGaD
Ketoconazole—CYP51A1—Metabolism—POMC—multiple sclerosis	5.45e-06	6.27e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—BCHE—multiple sclerosis	5.43e-06	6.25e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—GPC5—multiple sclerosis	5.41e-06	6.22e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.4e-06	6.21e-05	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism—APOE—multiple sclerosis	5.4e-06	6.2e-05	CbGpPWpGaD
Ketoconazole—CYP11B2—Metabolism—ALB—multiple sclerosis	5.24e-06	6.03e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—BCHE—multiple sclerosis	5.23e-06	6.01e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—SRM—multiple sclerosis	5.17e-06	5.94e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—RRM1—multiple sclerosis	5.14e-06	5.91e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—GPC5—multiple sclerosis	5.1e-06	5.86e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—GPC5—multiple sclerosis	5.05e-06	5.81e-05	CbGpPWpGaD
Ketoconazole—AR—Generic Transcription Pathway—MYC—multiple sclerosis	5.04e-06	5.79e-05	CbGpPWpGaD
Ketoconazole—CYP51A1—Metabolism—ALB—multiple sclerosis	4.97e-06	5.71e-05	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism—POMC—multiple sclerosis	4.96e-06	5.7e-05	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism—APOE—multiple sclerosis	4.94e-06	5.67e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.79e-06	5.51e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	4.72e-06	5.43e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	4.72e-06	5.43e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—BCHE—multiple sclerosis	4.72e-06	5.42e-05	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism—POMC—multiple sclerosis	4.64e-06	5.33e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.61e-06	5.3e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—RRM1—multiple sclerosis	4.59e-06	5.28e-05	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism—ALB—multiple sclerosis	4.52e-06	5.19e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—RRM1—multiple sclerosis	4.48e-06	5.15e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.35e-06	5e-05	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—APOE—multiple sclerosis	4.33e-06	4.98e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—BCHE—multiple sclerosis	4.33e-06	4.97e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—GPC5—multiple sclerosis	4.32e-06	4.96e-05	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism—POMC—multiple sclerosis	4.24e-06	4.87e-05	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism—ALB—multiple sclerosis	4.23e-06	4.86e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—RRM1—multiple sclerosis	4.22e-06	4.85e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—RRM1—multiple sclerosis	4.19e-06	4.81e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.13e-06	4.75e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.12e-06	4.74e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.05e-06	4.65e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.99e-06	4.59e-05	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism—ALB—multiple sclerosis	3.87e-06	4.44e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.85e-06	4.43e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.74e-06	4.3e-05	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—POMC—multiple sclerosis	3.72e-06	4.28e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.64e-06	4.19e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.64e-06	4.19e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—APOE—multiple sclerosis	3.62e-06	4.16e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—RRM1—multiple sclerosis	3.58e-06	4.11e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.56e-06	4.09e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—BCHE—multiple sclerosis	3.49e-06	4.01e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.43e-06	3.94e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—BCHE—multiple sclerosis	3.41e-06	3.92e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.41e-06	3.92e-05	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—ALB—multiple sclerosis	3.39e-06	3.9e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.33e-06	3.83e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—APOE—multiple sclerosis	3.27e-06	3.76e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.25e-06	3.73e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—BCHE—multiple sclerosis	3.22e-06	3.7e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—APOE—multiple sclerosis	3.15e-06	3.62e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.13e-06	3.59e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—POMC—multiple sclerosis	3.11e-06	3.57e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.06e-06	3.52e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—BCHE—multiple sclerosis	2.95e-06	3.4e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—APOE—multiple sclerosis	2.84e-06	3.26e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—ALB—multiple sclerosis	2.83e-06	3.26e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—POMC—multiple sclerosis	2.81e-06	3.23e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.79e-06	3.21e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.79e-06	3.21e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.78e-06	3.19e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.76e-06	3.17e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—POMC—multiple sclerosis	2.7e-06	3.11e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.64e-06	3.03e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—APOE—multiple sclerosis	2.6e-06	2.99e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.59e-06	2.98e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—BCHE—multiple sclerosis	2.57e-06	2.96e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—ALB—multiple sclerosis	2.56e-06	2.94e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.54e-06	2.92e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—ALB—multiple sclerosis	2.47e-06	2.83e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—POMC—multiple sclerosis	2.44e-06	2.8e-05	CbGpPWpGaD
Ketoconazole—AR—Gene Expression—MYC—multiple sclerosis	2.43e-06	2.79e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.43e-06	2.79e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.4e-06	2.76e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.38e-06	2.74e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—POMC—multiple sclerosis	2.24e-06	2.57e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—ALB—multiple sclerosis	2.22e-06	2.56e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.17e-06	2.5e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—APOE—multiple sclerosis	2.1e-06	2.41e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.05e-06	2.36e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—APOE—multiple sclerosis	2.05e-06	2.36e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—ALB—multiple sclerosis	2.04e-06	2.34e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—APOE—multiple sclerosis	1.94e-06	2.23e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—POMC—multiple sclerosis	1.8e-06	2.07e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—APOE—multiple sclerosis	1.78e-06	2.04e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—POMC—multiple sclerosis	1.76e-06	2.03e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—POMC—multiple sclerosis	1.67e-06	1.91e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—ALB—multiple sclerosis	1.64e-06	1.89e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—ALB—multiple sclerosis	1.61e-06	1.85e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—APOE—multiple sclerosis	1.59e-06	1.82e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.59e-06	1.82e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—APOE—multiple sclerosis	1.55e-06	1.78e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—POMC—multiple sclerosis	1.53e-06	1.75e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—ALB—multiple sclerosis	1.52e-06	1.75e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—APOE—multiple sclerosis	1.46e-06	1.68e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—APOE—multiple sclerosis	1.45e-06	1.66e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—ALB—multiple sclerosis	1.39e-06	1.6e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—POMC—multiple sclerosis	1.36e-06	1.57e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—POMC—multiple sclerosis	1.33e-06	1.53e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—POMC—multiple sclerosis	1.25e-06	1.44e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—POMC—multiple sclerosis	1.24e-06	1.43e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—ALB—multiple sclerosis	1.24e-06	1.43e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—APOE—multiple sclerosis	1.24e-06	1.42e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—ALB—multiple sclerosis	1.21e-06	1.39e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—ALB—multiple sclerosis	1.14e-06	1.31e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—ALB—multiple sclerosis	1.13e-06	1.3e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—POMC—multiple sclerosis	1.06e-06	1.22e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—ALB—multiple sclerosis	9.68e-07	1.11e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—APOE—multiple sclerosis	9.54e-07	1.1e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—POMC—multiple sclerosis	8.2e-07	9.42e-06	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—ALB—multiple sclerosis	7.47e-07	8.59e-06	CbGpPWpGaD
